Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,254 | 181 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $823.44 | 42 | $0 (2024) |
| Lilly USA, LLC | $388.42 | 21 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $237.76 | 2 | $0 (2020) |
| Merck Sharp & Dohme LLC | $226.36 | 6 | $0 (2024) |
| Seagen Inc. | $210.59 | 11 | $0 (2023) |
| Celgene Corporation | $204.28 | 11 | $0 (2023) |
| Incyte Corporation | $172.47 | 8 | $0 (2024) |
| Eisai Inc. | $169.60 | 8 | $0 (2023) |
| Seattle Genetics, Inc. | $162.61 | 11 | $0 (2019) |
| Abbott Laboratories | $134.85 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $617.16 | 28 | AstraZeneca Pharmaceuticals LP ($165.80) |
| 2023 | $786.50 | 37 | Seagen Inc. ($154.37) |
| 2022 | $117.55 | 6 | AstraZeneca Pharmaceuticals LP ($58.72) |
| 2020 | $397.98 | 10 | Janssen Scientific Affairs, LLC ($125.00) |
| 2019 | $908.34 | 32 | AstraZeneca Pharmaceuticals LP ($132.24) |
| 2018 | $968.00 | 40 | AstraZeneca Pharmaceuticals LP ($262.04) |
| 2017 | $458.35 | 28 | Celgene Corporation ($139.32) |
All Payment Transactions
181 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/02/2024 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $23.37 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Oncology | ||||||
| 07/30/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Oncology | ||||||
| 07/26/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $33.06 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: ONCOLOGY | ||||||
| 06/21/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: Oncology | ||||||
| 06/15/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: ONCOLOGY | ||||||
| 06/07/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $29.03 | General |
| Category: Hematology/Oncology | ||||||
| 05/28/2024 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Oncology | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Oncology | ||||||
| 05/10/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $24.21 | General |
| Category: Oncology | ||||||
| 04/23/2024 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Oncology | ||||||
| 04/10/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: ONCOLOGY | ||||||
| 04/01/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Oncology | ||||||
| 03/29/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $27.36 | General |
| Category: Hematology/Oncology | ||||||
| 03/05/2024 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: BioOncology | ||||||
| 03/01/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: ONCOLOGY | ||||||
| 02/28/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $2.59 | General |
| Category: Oncology | ||||||
| 02/27/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Oncology | ||||||
| 02/23/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Oncology | ||||||
| 02/15/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Oncology | ||||||
| 02/09/2024 | PFIZER INC. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Oncology | ||||||
| 02/06/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: ONCOLOGY | ||||||
| 01/25/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Oncology | ||||||
| 01/16/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $18.57 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,518 | 2,575 | $437,126 | $81,321 |
| 2022 | 15 | 1,381 | 2,355 | $416,085 | $81,260 |
| 2021 | 16 | 1,498 | 2,468 | $421,083 | $88,457 |
| 2020 | 15 | 1,366 | 2,231 | $367,757 | $78,643 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 663 | 1,153 | $182,174 | $33,332 | 18.3% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 149 | 336 | $117,264 | $22,190 | 18.9% |
| 88361 | Microscopic genetic analysis of tumor, using computer-assisted technology | Facility | 2023 | 35 | 137 | $25,482 | $4,786 | 18.8% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 52 | 164 | $20,008 | $3,711 | 18.5% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 103 | 128 | $16,384 | $3,565 | 21.8% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2023 | 26 | 27 | $17,901 | $3,131 | 17.5% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 24 | 61 | $11,163 | $2,035 | 18.2% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 176 | 217 | $10,416 | $1,963 | 18.8% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2023 | 23 | 37 | $11,840 | $1,840 | 15.5% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2023 | 89 | 92 | $8,372 | $1,796 | 21.5% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 25 | 43 | $3,827 | $870.44 | 22.7% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 65 | 81 | $4,293 | $806.66 | 18.8% |
| 88363 | Examination of archival tissue for genetic analysis | Facility | 2023 | 44 | 51 | $4,998 | $805.80 | 16.1% |
| 89060 | Crystal identification from tissue or body fluid | Facility | 2023 | 24 | 26 | $2,366 | $373.10 | 15.8% |
| 88302 | Pathology examination of tissue using a microscope | Facility | 2023 | 20 | 22 | $638.00 | $116.55 | 18.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 594 | 1,078 | $170,324 | $33,166 | 19.5% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 142 | 342 | $119,358 | $23,581 | 19.8% |
| 88361 | Microscopic genetic analysis of tumor, using computer-assisted technology | Facility | 2022 | 33 | 129 | $23,994 | $4,569 | 19.0% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2022 | 30 | 31 | $20,553 | $3,645 | 17.7% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 57 | 153 | $18,666 | $3,569 | 19.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 101 | 117 | $14,976 | $3,365 | 22.5% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2022 | 26 | 37 | $11,840 | $1,927 | 16.3% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2022 | 89 | 91 | $8,281 | $1,889 | 22.8% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2022 | 138 | 151 | $7,248 | $1,432 | 19.8% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2022 | 15 | 38 | $6,954 | $1,326 | 19.1% |
About Dr. Walter Klein, MD
Dr. Walter Klein, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Wynnewood, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326083833.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Walter Klein, MD has received a total of $4,254 in payments from pharmaceutical and medical device companies, with $617.16 received in 2024. These payments were reported across 181 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($4,254).
As a Medicare-enrolled provider, Klein has provided services to 5,763 Medicare beneficiaries, totaling 9,629 services with total Medicare billing of $329,681. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Wynnewood, PA
- Active Since 06/18/2006
- Last Updated 07/09/2007
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1326083833
Products in Payments
- ADCETRIS (Biological) $269.41
- ENHERTU (Biological) $245.96
- STELARA (Biological) $237.76
- VERZENIO (Drug) $224.32
- TAGRISSO (Drug) $203.04
- Revlimid (Drug) $163.61
- JAKAFI (Drug) $149.10
- AMPLATZER Occluders (Device) $134.85
- Lenvima (Drug) $126.31
- DIFICID (Drug) $125.00
- FARXIGA (Drug) $125.00
- NUZYRA (Drug) $122.90
- TUKYSA (Drug) $121.68
- OPDIVO (Biological) $120.50
- CYRAMZA (Drug) $114.38
- KRAZATI (Drug) $112.23
- Aimovig (Biological) $108.25
- GATTEX (Drug) $101.93
- KEYTRUDA (Biological) $101.36
- CALQUENCE (Drug) $94.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Wynnewood
Vlasta Zemba-Palko, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $2,721
Pradeep Bhagat, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $1,463
Robert Carr, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $1,301
Edina Grujic, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $898.99
Kimberly Heightchew, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $304.52
James Paulson, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $292.09